The two companies intend to leverage their complementary expertise and technology to bring a novel long acting injectable and drug product manufacturing platform to market. SACRAMENTO, Calif., Aug. 12 ...

A company that formulates pharmaceuticals in a sterile environment is spending almost $30 million to expand its headquarters ...

WuXi STA launched a high potency, fully-automated sterile injectable manufacturing line at its drug product site in Wuxi City, China. The new line has an annual capacity of 12 million units and meets ...

This report by Towards Healthcare, a sister firm of Precedence Research, provides a focused overview of the evolving CDMO aseptic filling solutions landscape, highlighting the forces shaping demand ...

-Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation Amneal will install dedicated manufacturing ...